Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2006 (Vol. 26, No. 20)

BioChemWeb

URL:www.biochemweb.org
  • Beautiful hierarchical design
  • None
Unless I’m not recalling things correctly, the Virtual Library of Biochemistry, Molecular Biology, and Cell Biology housed at “BioChemWeb” used to be elsewhere. The move has been good. In its current location, the site is thriving with a well thought out organizational scheme that is thorough yet compact and tidy. The site’s hierarchical design deserves a lot of credit. Unlike other Virtual Libraries I’ve seen, “BioChemWeb’s” opening page doesn’t require scrolling to completely view, isn’t crowded, and actually is visually attractive. The central area of the page links to subject pages, such as Angiogenesis, Apoptosis, Cell Cycle/Cytokinesis, Microscopy, Structural Biology, and more. On a portion of the page are links to General Resources/Tutorials, Research Groups, Databases/Tools, Methods, Software Vendors, and more. Whoever put this together knew what they doing.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »